Springworks Farm, a major regional producer of greenhouse grown lettuce, has shuttered and is selling its sprawling Lisbon ...

Merck KGaA has agreed to buy biotechnology company SpringWorks Therapeutics, announcing Monday a $3.9 billion deal after months of negotiations over an acquisition. The German pharmaceutical firm will ...

Carillon Tower Advisers, an investment management company, released its "Carillon Eagle Small Cap Growth Fund" first quarter 2025 investor letter. A copy of the letter can be downloaded here.

Investors with a lot of money to spend have taken a bearish stance on SpringWorks Therapeutics (NASDAQ:SWTX). And retail traders should know. We noticed this today when the trades showed up on ...

Shares of SpringWorks Therapeutics SWTX have rallied 32.9% in the past three months compared with the industry’s increase of 2.7%. Here, we discuss the reasons for the same. Strong Launch of SWTX's ...

Word of the potential acquisition comes as SpringWorks awaits an FDA approval decision on its MEK inhibitor mirdametinib toward the end of February. (AndreyPopov ...

Eight years after being spun out from Pfizer, Connecticut rare disease specialist SpringWorks Therapeutics has gained its second FDA approval in 15 months. (SpringWorks Therapeutics) After Merck ...

Financial giants have made a conspicuous bearish move on SpringWorks Therapeutics. Our analysis of options history for SpringWorks Therapeutics (NASDAQ:SWTX) revealed 9 unusual trades. Delving into ...

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

SpringWorks Therapeutics (SWTX) continues to be a strong pharmaceutical company because of the progress it has been able to make thus far. First and foremost, it was able to achieve FDA approval of ...

Shares of SpringWorks Therapeutics Inc. were up 14.9% in premarket trading on Tuesday after the company said a late-stage clinical trial evaluating its treatment for patients with progressing desmoid ...